Argitalpenak

CITA-Alzhemirren ekoizpen zientifikoan 105 lan (94 artikulu zientifiko) argitaratu dira 2010eko azaro eta 2021eko maiatz bitartean (iturria, Web of Science).

Irakurri gehiago

Argitalpen horiek 2.127 artikulutan izan dira hizpide. Guztira 2.324 aipamen egin dira, eta horietatik 2.251 ez dira geuk eginak.

Partekatzeko

Aldizkari zientifikoetan argitaratutako artikuluen % 70etik gora lehenengo kuartileko aldizkarietan argitaratu dira.

2019

  • Martinez de Lizarduy, U., et al. ALZUMERIC: A decision support system for diagnosis and monitoring of cognitive impairment Loquens, 2017. 4(1).
  • Lleo, Alberto; Nunez-Llaves, Raul; Alcolea, Daniel; […]Martinez-Lage, Pablo; […]Belbin, Olivia. Changes in Synaptic ProteinsPrecede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid Molecular & cellular proteomics : MCP Doi: 10.1074/mcp.RA118.001290
  • Stamate, Daniel; Kim, Min; Proitsi, Petroula; […]Martinez-Lage,Pablo; […] A metabolite-based machine learning approach to diagnose Alzheimer-type dementiain blood: Results from the European MedicalInformation Framework for Alzheimer disease biomarker discovery cohort Alzheimer's & dementia (New York, N. Y.) Doi: 10.1016/j.trci.2019.11.001
  • Lleo, Alberto; Nunez-Llaves, Raul; Alcolea, Daniel; […]Tainta, Mikel; […] Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid MOLECULAR & CELLULAR PROTEOMICS Doi: 10.1074/mcp.RA118.001290
  • Kim, Min; Snowden, Stuart; Suvitaival, Tommi; […]Martinez-Lage, Pablo; […]Lovestone, Simon; Legido-Quigley, Cristina. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in theEuropean Medical Information Framework for Alzheimer's Disease biomarker discovery cohort ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.03.004
  • Shi, Liu; Westwood, Sarah; Baird, Alison L.; […] Martinez-Lage, Pablo; Tainta, Mikel; […] Nevado-Holgado, Alejo J.Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.06.4951
  • Martinez de Lizarduy, U., et al. ALZUMERIC: A decision support system for diagnosis and monitoring of cognitive impairment Loquens, 2017. 4(1).
  • Lleo, Alberto; Nunez-Llaves, Raul; Alcolea, Daniel; […]Martinez-Lage, Pablo; […]Belbin, Olivia. Changes in Synaptic ProteinsPrecede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid Molecular & cellular proteomics : MCP Doi: 10.1074/mcp.RA118.001290
  • Stamate, Daniel; Kim, Min; Proitsi, Petroula; […]Martinez-Lage,Pablo; […] A metabolite-based machine learning approach to diagnose Alzheimer-type dementiain blood: Results from the European MedicalInformation Framework for Alzheimer disease biomarker discovery cohort Alzheimer's & dementia (New York, N. Y.) Doi: 10.1016/j.trci.2019.11.001
  • Lleo, Alberto; Nunez-Llaves, Raul; Alcolea, Daniel; […]Tainta, Mikel; […] Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid MOLECULAR & CELLULAR PROTEOMICS Doi: 10.1074/mcp.RA118.001290
  • Kim, Min; Snowden, Stuart; Suvitaival, Tommi; […]Martinez-Lage, Pablo; […]Lovestone, Simon; Legido-Quigley, Cristina. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in theEuropean Medical Information Framework for Alzheimer's Disease biomarker discovery cohort ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.03.004
  • Shi, Liu; Westwood, Sarah; Baird, Alison L.; […] Martinez-Lage, Pablo; Tainta, Mikel; […] Nevado-Holgado, Alejo J.Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.06.4951
  • Lopez-de-Ipina, K., et al. Analysis of Disfluencies for automatic detection of Mild Cognitive Impartment: a deep learning approach 2017 International Conference and Workshop on Bioinspired Intelligence (IWOBI), Funchal, 2017, pp. 1-4. Doi: 10.1109/IWOBI.2017.7985526.
  • Mar, Javier; Arrospide, Arantzazu; Soto-Gordoa, Myriam; Iruin, Alvaro; Tainta, Mikel; Gabilondo, Andrea;Mar-Barrutia, Lore; Calvo, Montserrat; Mateos, Maider; Ibarrondo, Oliver. Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization NEUROPSYCHIATRIC DISEASEAND TREATMENT Doi: 10.2147/NDT.S209008
  • Sudre, Carole H.; Bocchetta, Martina; Heller, Carolin; […]Barandiaran, Myriam; Gabilondo, Alazne; Tainta, Mikel; de Arriba, Maria; […] GENFI. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study NEUROIMAGE-CLINICAL Doi: 10.1016/j.nicl.2019.102077
  • Iriondo, Ane; Tainta, Mikel; Saldias, Jon; Arriba, Maria; Ochoa, Begona; Goni, Felix M.; Martinez-Lage, Pablo;Abad-Garcia, Beatriz. Isopropanol extraction for cerebrospinal fluid lipidomic profiling analysis TALANTA Doi: 10.1016/j.talanta.2018.11.101
  • Martinez-Lage, Pablo; Tainta, Mikel; […] Blennow, Kaj. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.01.015
  • Mollica, Maria A.; Tort-Merino, Adria; Navarra, Jordi; […]Martinez-Lage, Pablo; Early detection of subtle motor dysfunction in cognitively normal subjects with amyloid-beta positivity CORTEX Doi: 10.1016/j.cortex.2019.07.021
  • Lopez-de-Ipina, K., et al. Analysis of Disfluencies for automatic detection of Mild Cognitive Impartment: a deep learning approach 2017 International Conference and Workshop on Bioinspired Intelligence (IWOBI), Funchal, 2017, pp. 1-4. Doi: 10.1109/IWOBI.2017.7985526.
  • Mar, Javier; Arrospide, Arantzazu; Soto-Gordoa, Myriam; Iruin, Alvaro; Tainta, Mikel; Gabilondo, Andrea;Mar-Barrutia, Lore; Calvo, Montserrat; Mateos, Maider; Ibarrondo, Oliver. Dementia-related neuropsychiatric symptoms: inequalities in pharmacological treatment and institutionalization NEUROPSYCHIATRIC DISEASEAND TREATMENT Doi: 10.2147/NDT.S209008
  • Sudre, Carole H.; Bocchetta, Martina; Heller, Carolin; […]Barandiaran, Myriam; Gabilondo, Alazne; Tainta, Mikel; de Arriba, Maria; […] GENFI. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study NEUROIMAGE-CLINICAL Doi: 10.1016/j.nicl.2019.102077
  • Iriondo, Ane; Tainta, Mikel; Saldias, Jon; Arriba, Maria; Ochoa, Begona; Goni, Felix M.; Martinez-Lage, Pablo;Abad-Garcia, Beatriz. Isopropanol extraction for cerebrospinal fluid lipidomic profiling analysis TALANTA Doi: 10.1016/j.talanta.2018.11.101
  • Martinez-Lage, Pablo; Tainta, Mikel; […] Blennow, Kaj. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.01.015
  • Mollica, Maria A.; Tort-Merino, Adria; Navarra, Jordi; […]Martinez-Lage, Pablo; Early detection of subtle motor dysfunction in cognitively normal subjects with amyloid-beta positivity CORTEX Doi: 10.1016/j.cortex.2019.07.021
  • Arbizu, J.; Marti, G.; Lorenzo-Bosquet, C.; […]Martinez-Lage, P.; […]Carrio, I. Clinical outcome of Amyloid PET: interim analysis of the Spanish Registry of amyloid PET; Spanish Registry Amyloid PET; PET ADDS Consortium EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Tort-Merino, Adria; Olives, Jaume; Leon, Maria; […]Martinez-Lage, Pablo; […] Tau Protein is Associated with Longitudinal Memory Decline in Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels JOURNAL OF ALZHEIMERS DISEASE Doi: 10.3233/JAD-190046
  • Perez-Grijalba, V; Romero, J.; Pesini, P.; […]Martinez-Lage, P.; […]Touchon, Jacques; AB255 Study Grp. Plasma A beta 42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE Doi: 10.14283/jpad.2018.41
  • Stern, Yaakov; Chetelat, Gael; Habeck, Christian; […]Estanga, Ainara; Martinez-Lage, Pablo; […] Mechanisms underlying resilience in ageing NATURE REVIEWS NEUROSCIENCE Doi: 10.1038/s41583-019-0138-0
  • Dias, Irundika H. K.; Borah, Khushboo; Amin, Berivan; […] Iriondo,Ane; Martinez-Lage, Pablo. Localisation of oxysterols at the sub-cellular level and in biological fluids JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY Doi: 10.1016/j.jsbmb.2019.105426
  • Perez-Grijalba, Virginia; Arbizu, Javier; Romero, Judith; […]Martinez-Lage, Pablo; […]Antunez, Carmen; AB255 Study Grp. Plasma A beta 42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study ALZHEIMERS RESEARCH & THERAPY Doi: 10.1186/s13195-019-0549-1
  • Arbizu, J.; Marti, G.; Lorenzo-Bosquet, C.; […]Martinez-Lage, P.; […]Carrio, I. Clinical outcome of Amyloid PET: interim analysis of the Spanish Registry of amyloid PET; Spanish Registry Amyloid PET; PET ADDS Consortium EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Tort-Merino, Adria; Olives, Jaume; Leon, Maria; […]Martinez-Lage, Pablo; […] Tau Protein is Associated with Longitudinal Memory Decline in Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels JOURNAL OF ALZHEIMERS DISEASE Doi: 10.3233/JAD-190046
  • Perez-Grijalba, V; Romero, J.; Pesini, P.; […]Martinez-Lage, P.; […]Touchon, Jacques; AB255 Study Grp. Plasma A beta 42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE Doi: 10.14283/jpad.2018.41
  • Stern, Yaakov; Chetelat, Gael; Habeck, Christian; […]Estanga, Ainara; Martinez-Lage, Pablo; […] Mechanisms underlying resilience in ageing NATURE REVIEWS NEUROSCIENCE Doi: 10.1038/s41583-019-0138-0
  • Dias, Irundika H. K.; Borah, Khushboo; Amin, Berivan; […] Iriondo,Ane; Martinez-Lage, Pablo. Localisation of oxysterols at the sub-cellular level and in biological fluids JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY Doi: 10.1016/j.jsbmb.2019.105426
  • Perez-Grijalba, Virginia; Arbizu, Javier; Romero, Judith; […]Martinez-Lage, Pablo; […]Antunez, Carmen; AB255 Study Grp. Plasma A beta 42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study ALZHEIMERS RESEARCH & THERAPY Doi: 10.1186/s13195-019-0549-1
  • Rittman, Timothy; Borchert, Robin; Jones, Simon; […] Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia NEUROBIOLOGY OF AGING Doi: 10.1016/j.neurobiolaging.2018.12.009
  • Barandiaran, Myriam; Moreno, Fermin; de Arriba, Maria; Indakoetxea, Begona; Boda, Irati; Gabilondo, Alazne;Tainta, Mikel; Lopez de Munain, Adolfo. Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>AProgranulin Mutation Carriers JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY Doi: 10.1017/S1355617718000735
  • Lleo, Alberto; Nunez-Llaves, Raul; Alcolea, Daniel; […]Martinez-Lage, Pablo […] Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid Molecular & cellular proteomics : MCP Doi: 10.1074/mcp.RA118.001290
  • Bos, Isabelle; Vos, Stephanie; Verhey, Frans; […]Martinez-Lage, Pablo; Tainta, Mikel; […]Visser, Pieter Jelle. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.01.004
  • Moreno-Grau, Sonia; de Rojas, Itziar; Hernandez, Isabel; […] Martinez-Lage Alvarez, P.; […] Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.06.4950
  • Sanchez-Juan, Pascual; Moreno, Sonia; de Rojaso, Itziar; […] Martinez-Lage Alvarez, P. […] GR ACE Study Grp; DEGESCO Consortium. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE epsilon 4 Non-carriers FRONTIERS IN AGING NEUROSCIENCE Doi: 10.3389/fnagi.2019.00327
  • Rittman, Timothy; Borchert, Robin; Jones, Simon; […] Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia NEUROBIOLOGY OF AGING Doi: 10.1016/j.neurobiolaging.2018.12.009
  • Barandiaran, Myriam; Moreno, Fermin; de Arriba, Maria; Indakoetxea, Begona; Boda, Irati; Gabilondo, Alazne;Tainta, Mikel; Lopez de Munain, Adolfo. Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>AProgranulin Mutation Carriers JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY Doi: 10.1017/S1355617718000735
  • Lleo, Alberto; Nunez-Llaves, Raul; Alcolea, Daniel; […]Martinez-Lage, Pablo […] Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid Molecular & cellular proteomics : MCP Doi: 10.1074/mcp.RA118.001290
  • Bos, Isabelle; Vos, Stephanie; Verhey, Frans; […]Martinez-Lage, Pablo; Tainta, Mikel; […]Visser, Pieter Jelle. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.01.004
  • Moreno-Grau, Sonia; de Rojas, Itziar; Hernandez, Isabel; […] Martinez-Lage Alvarez, P.; […] Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project ALZHEIMERS & DEMENTIA Doi: 10.1016/j.jalz.2019.06.4950
  • Sanchez-Juan, Pascual; Moreno, Sonia; de Rojaso, Itziar; […] Martinez-Lage Alvarez, P. […] GR ACE Study Grp; DEGESCO Consortium. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE epsilon 4 Non-carriers FRONTIERS IN AGING NEUROSCIENCE Doi: 10.3389/fnagi.2019.00327